ZENOTECH LABORATORIES
|
ZENOTECH LABORATORIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 1.36 | 1.90 | 3.63 | -0.20 | 1.77 |
| CEPS(Rs) | 2.52 | 3.07 | 4.78 | 0.86 | 2.56 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 14.84 | 13.48 | 11.57 | 7.93 | 8.13 |
| Tax Rate(%) | 25.51 | 20.11 | -123.97 | - | - |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 42.18 | 48.80 | 47.75 | 28.42 | 34.51 |
| EBIT Margin(%) | 27.29 | 34.45 | 30.40 | 1.48 | 44.85 |
| Pre Tax Margin(%) | 27.29 | 34.18 | 27.08 | -5.41 | 41.42 |
| PAT Margin (%) | 20.32 | 27.31 | 60.65 | -5.41 | 41.42 |
| Cash Profit Margin (%) | 37.68 | 44.22 | 79.72 | 23.35 | 60.06 |
| Performance Ratios | |||||
| ROA(%) | 8.68 | 13.37 | 26.45 | -1.42 | 12.67 |
| ROE(%) | 9.60 | 15.15 | 37.26 | -2.48 | 24.35 |
| ROCE(%) | 12.89 | 18.39 | 15.26 | 0.48 | 18.32 |
| Asset Turnover(x) | 0.43 | 0.49 | 0.44 | 0.26 | 0.31 |
| Sales/Fixed Asset(x) | 0.37 | 0.40 | 0.35 | 0.26 | 0.40 |
| Working Capital/Sales(x) | 3.23 | -123.98 | -4.46 | -2.95 | -0.88 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 2.70 | 2.50 | 2.83 | 3.81 | 2.47 |
| Receivable days | 29.38 | 31.20 | 38.59 | 46.02 | 29.56 |
| Inventory Days | 7.51 | - | 0.61 | 1.27 | 4.76 |
| Payable days | - | - | - | - | 3,153.54 |
| Valuation Parameters | |||||
| PER(x) | 43.47 | 24.79 | 13.86 | - | 8.32 |
| PCE(x) | 23.45 | 15.31 | 10.54 | 40.76 | 5.74 |
| Price/Book(x) | 3.98 | 3.49 | 4.35 | 4.41 | 1.81 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 8.35 | 6.51 | 8.50 | 10.33 | 4.12 |
| EV/Core EBITDA(x) | 18.71 | 12.67 | 17.18 | 34.15 | 10.57 |
| EV/EBIT(x) | 30.61 | 18.89 | 27.97 | 697.37 | 9.19 |
| EV/CE(x) | 3.77 | 3.36 | 3.80 | 2.70 | 1.25 |
| M Cap / Sales | 8.83 | 6.77 | 8.40 | 9.52 | 3.45 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -3.75 | 16.02 | 62.91 | -13.74 | 99.71 |
| Core EBITDA Growth(%) | -16.34 | 20.44 | 166.48 | -33.12 | 751.01 |
| EBIT Growth(%) | -23.76 | 31.47 | 3,244.31 | -97.15 | 487.80 |
| PAT Growth(%) | -28.37 | -47.76 | 1,925.03 | -111.27 | 444.66 |
| EPS Growth(%) | -28.37 | -47.76 | 1,925.01 | -111.27 | 444.66 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | 0.08 | 0.43 | 0.38 |
| Current Ratio(x) | 1.93 | 0.98 | 0.47 | 0.49 | 0.16 |
| Quick Ratio(x) | 1.87 | 0.98 | 0.47 | 0.49 | 0.16 |
| Interest Cover(x) | - | 130.25 | 9.15 | 0.21 | 13.08 |
| Total Debt/Mcap(x) | - | - | 0.02 | 0.10 | 0.21 |
Compare Financial Ratios of peers of ZENOTECH LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZENOTECH LABORATORIES | ₹431.3 Cr | -0.6% | -7% | 8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
| CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics | |
ZENOTECH LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZENOTECH LABORATORIES | -0.6% |
-7% |
8% |
| SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses
